Putnam Investments’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-36,713
Closed -$2.17M 1222
2022
Q3
$2.17M Buy
+36,713
New +$2.17M ﹤0.01% 714